Isotechnika Pharma Inc IPHAF

lets count the chicken..

[labumba]

what the sp would be like once approved in six months ?

[WASKERWISK]

Well there are a lot of variables there and as Macbeth points out some artificial restraints on price due to all the buying of shares at basement prices of which there are probably several million – you can get some very counter intuitive results in these situations – do not be totally surprised for example if our closing price today is lower than it was yesterday – the reason of course is that

[InterestedParty]

Okay thats pretty depressing, however, I disagree for the main reason that we now should get some institutional buying happening.  If and when this happens, you should clear out some of that garbage pretty easily especially nearing the approval stage.  I would predict 1.00 + after approval.  Although there are some shares to clear out at the lower prices, lets face it, we have not

[labumba]

if you look at the penny stock market , the potential of great gain from this stock is far better than lots of mining penny stocks in the market...I think it will lure lots of new buyers as 25 cents a piece is a screaming buy....it is easy to hit a buck or better when approved

[MementoMori]

>what the sp would be like once approved in six months ? Speculating on an uncertain future is probably a waste of time (as longtime investors in ISA have learned the hard way), but here are some relevant, non-speculative facts. According to wrongdiagnosis.com, the incidence of uveitis is 1 in 118 or 0.85%. I think this is the point incidence, not the lifetime incidence. The combined

[labumba]

Man man man as i said before....nothing better than " oral form ".....patients got the right treament by poping few pills a day..... the bottom line....your eye balls can survive....and it wont break your walletI can see the future of Voclosporin......a popular drug name in pharmacy.......keep some shares for your retirement

[go4future]

Actually, according to the article I had posted earlier, prevalence of Uveitis in India alone is estimated to be 8.5 million! https://www.ijo.in/article.asp?issn=0301-4738;year=2010;volume=58;issue=1;spage=1;epage=2;aulast=Sangwan Quote from the article: "Intraocular inflammatory disease, or uveitis, is a serious problem for the ophthalmic practitioner. It affects patients in the